Catalyst pharmaceuticals, inc. (CPRX)
Income statement / Quarterly
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12Sep'12Jun'12Mar'12Dec'11Sep'11Jun'11Mar'11Sep'10Jun'10
Revenues:
Product revenue, net

29,136

30,122

30,897

28,837

12,448

-

-

-

0

-

-

-

-

-

-

-

0

-

-

-

0

-

-

-

0

-

-

-

-

-

-

-

-

-

0

0

-

-

-

Operating costs and expenses:
Cost of sales

4,150

4,398

4,387

4,261

1,711

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Research and development

4,222

6,308

4,597

4,629

3,307

8,416

4,538

3,704

3,259

3,404

2,704

2,451

2,813

2,820

2,493

2,508

3,546

3,831

3,042

2,577

2,349

2,384

2,885

2,098

2,748

2,068

2,804

2,132

1,092

744

654

532

727

960

614

905

903

500

797

Selling, general and administrative

10,063

11,409

8,067

8,987

8,416

6,926

3,644

2,631

2,674

2,107

1,601

1,729

1,865

1,493

1,420

2,305

2,691

2,360

1,974

2,319

1,942

1,599

1,223

891

759

638

441

521

613

760

628

534

637

1,074

516

491

615

408

535

Total operating costs and expenses

18,436

22,115

17,052

17,878

13,436

15,343

8,182

6,335

5,933

5,511

4,306

4,181

4,679

4,314

3,914

4,814

6,237

6,191

5,017

4,897

4,291

3,983

4,109

2,990

3,508

2,706

3,245

2,653

1,705

1,505

1,283

1,067

1,364

2,034

1,131

1,397

1,519

908

1,333

Operating income (loss)

10,699

8,006

13,845

10,959

-987

-14,843

-8,182

-6,335

-5,933

-5,511

-4,306

-4,181

-4,679

-4,314

-3,914

-4,814

-6,237

-6,191

-5,017

-4,897

-4,291

-3,983

-4,109

-2,990

-3,508

-2,706

-3,245

-2,653

-1,705

-1,505

-1,283

-1,067

-1,364

-2,034

-1,131

-1,397

-1,519

-908

-1,333

Other income, net

336

398

393

450

343

343

343

370

233

124

129

91

109

43

66

92

117

-13

46

4

61

21

5

15

32

22

10

8

6

9

2

1

1

2

3

3

2

4

4

Change in fair value of warrants liability

-

-

-

-

-

-

-

-

-

0

0

-210

397

-106

106

-152

-733

-389

-521

-333

1,180

-472

906

223

335

-1,330

2,676

498

45

-3,521

1,340

776

274

-

-

-

-

-

-

Net income (loss) before income taxes

11,035

8,405

14,238

11,409

-644

-14,499

-7,838

-5,965

-5,699

-5,387

-4,177

-3,879

-4,967

-4,163

-3,953

-4,568

-5,386

-5,815

-4,449

-4,558

-5,410

-3,490

-5,009

-3,198

-3,811

-1,354

-5,912

-3,143

-1,744

-76

-2,621

-289

-1,089

-2,351

-1,127

-1,394

-1,517

-903

-1,328

Provision for income taxes

609

-

608

449

-

-

-

-

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

-

-

0

0

0

0

0

0

0

0

0

0

0

0

Net income (loss)

10,426

7,929

13,630

10,959

-644

-14,499

-7,838

-5,965

-5,699

-5,387

-4,177

-3,879

-4,967

-4,163

-3,953

-4,568

-5,386

-5,815

-4,449

-4,558

-5,410

-3,490

-5,009

-3,198

-3,811

-1,354

-5,912

-3,143

-1,744

-76

-2,621

-289

-1,089

-2,351

-1,127

-1,394

-1,517

-903

-1,328

Net income (loss) per share:
Basic

0.10

0.08

0.13

0.11

-0.01

-

-0.08

-0.06

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Diluted

0.10

0.08

0.13

0.10

-0.01

-

-0.08

-0.06

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Weighted average shares outstanding:
Basic

103,407

103,186

102,974

102,869

102,747

-

102,641

102,596

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Diluted

106,534

108,361

107,045

105,928

102,747

-

102,641

102,596

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net loss per share - basic and diluted

-

-

-

-

-

-

-

-

-0.06

-0.05

-0.05

-0.05

-0.06

-0.04

-0.05

-0.06

-0.07

-0.07

-0.05

-0.06

-0.07

-0.05

-0.07

-0.05

-0.07

-0.02

-0.13

-0.08

-0.04

-0.01

-0.08

-0.01

-0.04

-0.10

-0.05

-0.06

-0.08

-0.05

-0.07

Weighted average shares outstanding - basic and diluted

-

-

-

-

-

-

-

-

102,557

91,533

84,797

83,905

82,972

82,899

82,870

82,870

82,860

82,886

82,470

82,037

76,039

69,094

67,169

66,167

54,138

54,257

44,686

41,445

41,420

36,437

32,132

26,851

24,710

23,681

21,654

21,654

19,922

18,821

18,043

Net income (loss)

10,426

7,929

13,630

10,959

-644

-14,499

-7,838

-5,965

-5,699

-5,387

-4,177

-3,879

-4,967

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Other comprehensive income (loss):
Unrealized gain (loss) on available-for-sale securities

74

-9

-2

28

13

25

-9

-14

-21

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Comprehensive income (loss)

10,500

7,919

13,627

10,988

-630

-14,473

-7,848

-5,979

-5,721

-5,387

-4,177

-3,879

-4,967

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-